FHIR IG Statistics: PlanDefinition/IMMZD2DTPoliobOPVIPV

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source

{
  "resourceType": "PlanDefinition",
  "id": "IMMZD2DTPoliobOPVIPV",
  "meta": {
    "profile": [
      "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-recommendationdefinition",
      "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareableplandefinition",
      "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishableplandefinition"
    ]
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability",
      "valueCode": "computable"
    }
  ],
  "url": "http://smart.who.int/immunizations/PlanDefinition/IMMZD2DTPoliobOPVIPV",
  "version": "0.2.0",
  "name": "IMMZD2DTPoliobOPVIPV",
  "title": "IMMZ.D2.DT.Polio.bOPV plus IPV",
  "type": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/plan-definition-type",
        "code": "eca-rule"
      }
    ]
  },
  "status": "draft",
  "experimental": false,
  "date": "2025-08-08T19:12:11+00:00",
  "publisher": "WHO",
  "contact": [
    {
      "name": "WHO",
      "telecom": [
        {
          "system": "url",
          "value": "http://who.int"
        }
      ]
    }
  ],
  "description": "IMMZ.D2.DT.Polio.bOPV plus IPV\n \"Bivalent oral polio vaccine (bOPV) plus inactivated polio vaccine (IPV)\" schedule (applicable for all countries)",
  "relatedArtifact": [
    {
      "type": "citation",
      "citation": "WHO recommendations for routine immunization - summary tables (January 2025)"
    }
  ],
  "library": [
    "http://smart.who.int/immunizations/Library/IMMZD2DTPoliobOPVIPVLogic"
  ],
  "action": [
    {
      "extension": [
        {
          "url": "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-rationale",
          "valueMarkdown": "For all countries using OPV in their national immunization programme, WHO recommends 3 doses of bOPV and 2 doses of IPV.  \n  The preferred schedule is to administer the 3 doses of bOPV starting from the minimum age of 6 weeks, with at least a 4 week-interval \n  between doses. The first IPV dose should be administered from a minimum of 14 weeks of age (with the third dose of the \n  diphtheria–tetanus–pertussis vaccine [DTP3] or pentavalent vaccine [penta3]), with the second IPV dose being given at least \n  4 months later (possibly coinciding with other vaccines administered at 9 months of age).  Note: Based on local epidemiology, \n  programmatic implications and feasibility of delivery, countries may choose an alternative “early IPV schedule” starting with \n  the first IPV dose at 6 weeks of age (with DTP1/penta1) and the second IPV dose at 14 weeks (with DTP3/penta3)."
        }
      ],
      "title": "Determine if the client is due for a poliovirus vaccination according to the national immunization schedule",
      "description": "Determine if the client is due for a poliovirus vaccination according to the national immunization schedule\n\"Bivalent oral polio vaccine (bOPV) plus inactivated polio vaccine (IPV)\" schedule (applicable for all countries)",
      "condition": [
        {
          "kind": "applicability",
          "expression": {
            "description": "Client is due for bOPV vaccination",
            "language": "text/cql-identifier",
            "expression": "Client is due for bOPV vaccination"
          }
        }
      ],
      "definitionCanonical": "http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTPolioOPVMR",
      "dynamicValue": [
        {
          "path": "status",
          "expression": {
            "language": "text/cql-expression",
            "expression": "'draft'"
          }
        },
        {
          "path": "intent",
          "expression": {
            "language": "text/cql-expression",
            "expression": "'proposal'"
          }
        }
      ]
    },
    {
      "extension": [
        {
          "url": "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-rationale",
          "valueMarkdown": "For all countries using OPV in their national immunization programme, WHO recommends 3 doses of bOPV and 2 doses of IPV.  \n  The preferred schedule is to administer the 3 doses of bOPV starting from the minimum age of 6 weeks, with at least a 4 week-interval \n  between doses. The first IPV dose should be administered from a minimum of 14 weeks of age (with the third dose of the \n  diphtheria–tetanus–pertussis vaccine [DTP3] or pentavalent vaccine [penta3]), with the second IPV dose being given at least \n  4 months later (possibly coinciding with other vaccines administered at 9 months of age).  Note: Based on local epidemiology, \n  programmatic implications and feasibility of delivery, countries may choose an alternative “early IPV schedule” starting with \n  the first IPV dose at 6 weeks of age (with DTP1/penta1) and the second IPV dose at 14 weeks (with DTP3/penta3)."
        }
      ],
      "title": "Determine if the client is due for a poliovirus vaccination according to the national immunization schedule",
      "description": "Determine if the client is due for a poliovirus vaccination according to the national immunization schedule\n\"Bivalent oral polio vaccine (bOPV) plus inactivated polio vaccine (IPV)\" schedule (applicable for all countries)",
      "condition": [
        {
          "kind": "applicability",
          "expression": {
            "description": "Client is due for bOPV and IPV vaccination",
            "language": "text/cql-identifier",
            "expression": "Client is due for bOPV and IPV vaccination"
          }
        }
      ],
      "definitionCanonical": "http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTPolioOPVMR",
      "dynamicValue": [
        {
          "path": "status",
          "expression": {
            "language": "text/cql-expression",
            "expression": "'draft'"
          }
        },
        {
          "path": "intent",
          "expression": {
            "language": "text/cql-expression",
            "expression": "'proposal'"
          }
        }
      ]
    },
    {
      "extension": [
        {
          "url": "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-rationale",
          "valueMarkdown": "For all countries using OPV in their national immunization programme, WHO recommends 3 doses of bOPV and 2 doses of IPV.  \n  The preferred schedule is to administer the 3 doses of bOPV starting from the minimum age of 6 weeks, with at least a 4 week-interval \n  between doses. The first IPV dose should be administered from a minimum of 14 weeks of age (with the third dose of the \n  diphtheria–tetanus–pertussis vaccine [DTP3] or pentavalent vaccine [penta3]), with the second IPV dose being given at least \n  4 months later (possibly coinciding with other vaccines administered at 9 months of age).  Note: Based on local epidemiology, \n  programmatic implications and feasibility of delivery, countries may choose an alternative “early IPV schedule” starting with \n  the first IPV dose at 6 weeks of age (with DTP1/penta1) and the second IPV dose at 14 weeks (with DTP3/penta3)."
        }
      ],
      "title": "Determine if the client is due for a poliovirus vaccination according to the national immunization schedule",
      "description": "Determine if the client is due for a poliovirus vaccination according to the national immunization schedule\n\"Bivalent oral polio vaccine (bOPV) plus inactivated polio vaccine (IPV)\" schedule (applicable for all countries)",
      "condition": [
        {
          "kind": "applicability",
          "expression": {
            "description": "Client is due for bOPV and IPV vaccination",
            "language": "text/cql-identifier",
            "expression": "Client is due for bOPV and IPV vaccination"
          }
        }
      ],
      "definitionCanonical": "http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTPolioIPVMR",
      "dynamicValue": [
        {
          "path": "status",
          "expression": {
            "language": "text/cql-expression",
            "expression": "'draft'"
          }
        },
        {
          "path": "intent",
          "expression": {
            "language": "text/cql-expression",
            "expression": "'proposal'"
          }
        }
      ]
    },
    {
      "extension": [
        {
          "url": "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-rationale",
          "valueMarkdown": "For all countries using OPV in their national immunization programme, WHO recommends 3 doses of bOPV and 2 doses of IPV.  \n  The preferred schedule is to administer the 3 doses of bOPV starting from the minimum age of 6 weeks, with at least a 4 week-interval \n  between doses. The first IPV dose should be administered from a minimum of 14 weeks of age (with the third dose of the \n  diphtheria–tetanus–pertussis vaccine [DTP3] or pentavalent vaccine [penta3]), with the second IPV dose being given at least \n  4 months later (possibly coinciding with other vaccines administered at 9 months of age).  Note: Based on local epidemiology, \n  programmatic implications and feasibility of delivery, countries may choose an alternative “early IPV schedule” starting with \n  the first IPV dose at 6 weeks of age (with DTP1/penta1) and the second IPV dose at 14 weeks (with DTP3/penta3)."
        }
      ],
      "title": "Determine if the client is due for a poliovirus vaccination according to the national immunization schedule",
      "description": "Determine if the client is due for a poliovirus vaccination according to the national immunization schedule\n\"Bivalent oral polio vaccine (bOPV) plus inactivated polio vaccine (IPV)\" schedule (applicable for all countries)",
      "condition": [
        {
          "kind": "applicability",
          "expression": {
            "description": "Client is due for IPV vaccination",
            "language": "text/cql-identifier",
            "expression": "Client is due for IPV vaccination"
          }
        }
      ],
      "definitionCanonical": "http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTPolioIPVMR",
      "dynamicValue": [
        {
          "path": "status",
          "expression": {
            "language": "text/cql-expression",
            "expression": "'draft'"
          }
        },
        {
          "path": "intent",
          "expression": {
            "language": "text/cql-expression",
            "expression": "'proposal'"
          }
        }
      ]
    },
    {
      "title": "Check for Guidance for the patient regarding IMMZ.D2.DT.Polio.bOPV plus IPV.",
      "description": "Show Guidance for the patient regarding IMMZ.D2.DT.Polio.bOPV plus IPV.",
      "condition": [
        {
          "kind": "applicability",
          "expression": {
            "description": "Has Guidance",
            "language": "text/cql-identifier",
            "expression": "Has Guidance"
          }
        }
      ],
      "definitionCanonical": "http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTCR",
      "dynamicValue": [
        {
          "path": "status",
          "expression": {
            "language": "text/cql-expression",
            "expression": "'active'"
          }
        },
        {
          "path": "payload.contentString",
          "expression": {
            "language": "text/cql-identifier",
            "expression": "Guidance"
          }
        },
        {
          "path": "category.coding",
          "expression": {
            "description": "Category of communication",
            "language": "text/cql-expression",
            "expression": "Code { system: 'http://terminology.hl7.org/CodeSystem/communication-category', code: 'alert' }"
          }
        },
        {
          "path": "priority",
          "expression": {
            "description": "Alert priority",
            "language": "text/cql-expression",
            "expression": "Code { system: 'http://hl7.org/fhir/request-priority', code: 'routine' }"
          }
        }
      ]
    }
  ]
}